Quetiapine Fumarate Tablet, Film Coated
Product Images NDC 63187-219

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 63187-219). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

63187-269-60 (63187 269 60)

Label for Quetiapine Fumarate 100 mg film coated tablets, pack of 30, by Proficient Rx LP. The label shows the product name, strength, dosage form, quantity, and states it is prescription only. It also includes manufacturer details (Intas Pharmaceuticals Limited, India), storage instructions, lot and expiration placeholders, and barcodes including an NDC number 63187-269-30.*

FDA Label Image

Quetiapine 50mg (Quetiapine 50mg)

Label for Quetiapine Fumarate 50 mg film coated tablets from Proficient Rx LP. The label indicates a package count of 30 tablets, with details including product ID PQ021930, manufacturer Intas Pharmaceuticals Limited, and storage conditions (20°-25°C). The label features dosage, drug description, QR code, barcode, and repackaging information from Thousand Oaks, CA.*

FDA Label Image

Figure 1 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 7) (Quetiapine Fig1)

A line graph depicting the proportion of patients with relapse (%) over time in weeks (0 to 100). Two lines represent different treatment groups: QTP + LIV/VAL (dashed line) and PLA + LIV/VAL (solid line). The graph shows relapse proportions increasing over time for both groups, with PLA + LIV/VAL having a higher relapse rate throughout compared to QTP + LIV/VAL.*

FDA Label Image

Figure 2 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 8) (Quetiapine Fig2)

A line graph showing the proportion of patients with relapse (%) on the vertical axis and time in weeks on the horizontal axis. Two lines compare relapse rates over time between QTP+ LIVAL and PLA+ LIVAL groups, illustrating relapse progression up to 100 weeks.*

FDA Label Image

Chemstructure (Quetiapine Str)

Chemical structure diagram of Quetiapine fumarate, showing the molecular arrangement of the quetiapine component and fumarate ion as represented in the structural formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.